5003 treat DL patient reg 3:Layout 1

First Page		Document Content
Date: 2011-03-25 02:39:46 Clinical research Motor neurone disease Pharmaceutical industry Rare diseases Disease registry Limb-girdle muscular dystrophy Clinical trial Congenital muscular dystrophy Amyotrophic lateral sclerosis Health Medicine Muscular dystrophy		5003 treat DL patient reg 3:Layout 1 Add to Reading List Source URL: www.ann.org.au Download Document from Source Website File Size: 132,35 KB Share Document on Facebook

	Caffeic acid phenethyl ester extends survival of a mouse model of amyotrophic lateral sclerosis DocID: 1qMIa - View Document
	Subject: Call for Letters of Intent to Target ALS Foundation for Young Investigator-led Collaborative Projects (YICPs) Dear Investigator, Target ALS Foundation is an independent non-profit 501(c)(3) foundation working DocID: 1qwy8 - View Document
	Postdoc position in environmental causes of DocID: 1qdo8 - View Document
	Vertrauensbildende Massnahmen ALS Diplomatie On start-up, between Vertrauensbildende Massnahmen ALS Diplomatie taking online partners by energy to your periods, options will be required too. The greenery is able also to DocID: 1pZjN - View Document
	READTHEORY ® TEACHING STUDENTS TO READ AND THINK CRITICALLY DocID: 1p6lY - View Document